Ironshore Pharmaceuticals & Development, Inc.
Records under this name other than the patents Ironshore Pharmaceuticals & Development, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 22 patents it holds.
Showing 1 to 6 of 6 · Back to Ironshore Pharmaceuticals & Development, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,617,651 | Compositions for Treatment of Attention Deficit Hyperactivity Disorder now held by Highland Therapeutics Inc. In force · Medium confidence | In force | Medium confidence | |
| 17/315,133 | Methylphenidate Compositions for Treatment of Attention Deficit Hyperactivity Disorder Abandoned Abandoned Jan 31, 2023 | Abandoned | Abandoned Jan 31, 2023 | |
| 17/316,252 | Methylphenidate Compositions for Treatment of Attention Deficit Hyperactivity Disorder Abandoned Abandoned Sep 15, 2026 | Abandoned | Abandoned Sep 15, 2026 | |
| 17/557,476 | Compositions for Treatment of Attention Deficit Hyperactivity Disorder Abandoned Abandoned Apr 5, 2024 | Abandoned | Abandoned Apr 5, 2024 | |
| 18/057,819 | Methylphenidate Compositions for Treatment of Attention Deficit Hyperactivity Disorder Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/267,000 | Compositions for Treatment of Attention Deficit Hyperactivity Disorder Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |